Idiopathic inflammatory myositis-associated interstitial lung disease: Ethnicity differences and lung function trends in a British cohort

Rheumatology (United Kingdom)

Volumn 51, Issue 10, 2012, Pages 1870-1876

  Chua, Felix ^a   Higton, Alexandra M ^a   Colebatch, Alexandra N ^b   O'reilly, Katherine ^b   Grubnic, Sisa ^a   Vlahos, Ioannis ^a   Edwards, Christopher J ^b   Kiely, Patrick D W ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Ethnicity; Idiopathic inflammatory myositis; Interstitial lung disease

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MYOSITIS; NEGRO; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; AUTOANTIBODIES; ENGLAND; FEMALE; HISTIDINE-TRNA LIGASE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; PREVALENCE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 84867127133     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes167     Document Type: Article

References (26)

1. Benbassat J, Gefel D, Larholt K et al. Prognostic factors in polymyositis/dermatomyositis: a computer-assisted analysis of ninety-two cases. Arthritis Rheum 1985;28:249-55.
2. Marie I, Hachulla E, Cherin P et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614-22.
3. Saketkoo LA, Ascherman DP, Cottin V et al. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev 2010;6:108-19.
4. Takizawa H, Shiga J, Moroi Y et al. Interstitial lung disease in dermatomyositis: clinicopathological study. J Rheumatol 1987;14:102-7.
5. Schnabel A, Reuter M, Biederer C, Richter C, Gross WL. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003;32:273-84.
6. Kang EH, Lee EB, Shin KC et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology 2005;44:1282-6.
7. Fathi M, Vikgren J, Boijsen M et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008;59:677-85.
8. Chen IJ, Jan Wu YJ, Lin CW et al. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 2009;28:639-46.
9. Ito M, Kaise S, Suzuki S et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol 1999;18:462-7.
10. Lee CS, Chen TL, Tzen CY et al. Idiopathic inflammatory myositis and diffuse alveolar damage. Clin Rheumatol 2002;21:391-6.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7, 403-7.
12. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991;325:1487-91.
13. UK Department of Health. Publications policy and guidance. http://www.dh.gov.uk/en/Publicationsand statistics/Publications/PublicationsPolicyAndGuidance/Browsable/DH-5319155 (May 2011, date last accessed).
14. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of Idiopathic Interstitial Pneumonias. General principles and recommendations. Am J Respir Crit Care Med 2002;165: 277-304.
15. Bradley B, Branley HM, Egan JJ et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63: v1-58.
16. Latsi PI, du Bois RM, Nicholson AG et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:531-7.
17. Marguerie C, Bunn CC, Beynon HL et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990;77:1019-38.
18. Chinoy H, Salway F, Fertig N et al. Clinical, serological and HLA profiles in non-Caucasian UK idiopathic inflammatory myopathy. Rheumatology 2009;48:591-2.
19. Betteridge ZE, Gunawardena H, McHugh NJ. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 2011;13:209-15.
20. Aduen JF, Zisman DA, Mobin SI et al. Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc 2007;82:48-54.
21. Morganroth PA, Kreider ME, Okawa J, Taylor L, Werth VP. Interstitial lung disease in classic and skin-predominant dermatomyositis. Arch Dermatol 2010;146:729-38.
22. Behr J, Furst DE. Pulmonary function tests. Rheumatology 2008;47(Suppl 5):v65-7.
23. Mino M, Noma S, Taguchi Y et al. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol 1997;169:83-7.
24. Douglas WW, Tazelaar HD, Hartman TE et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-5.
25. Bonnefoy O, Ferretti G, Calaque O et al. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol 2004;49: 235-44.
26. Tansey D, Wells AU, Colby TV et al. Varations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585-96.